COVID-19 is associated with a wide range of clinical manifestations, including autoimmune
features and autoantibody production. Here we develop three protein arrays to measure IgG …

Background As COVID-19 cases continue to rise globally, evidence from large randomized
controlled trials is still lacking. Currently, numerous trials testing potential treatment and …

A subgroup of COVID-19 patients develop very severe disease with requirement for ICU
treatment, ventilation, and ECMO therapy. Laboratory tests indicate that the immune and clotting …

Risk of severe coronavirus disease 2019 (COVID-19) after infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is increased in patients with certain …

Allergies, including asthma, food allergy and atopic dermatitis, are increasing in prevalence,
particularly in westernized countries. Although a detailed mechanistic explanation for this …

… Author links open overlay panel Chrysanthi Skevaki MD a b , Antonina Karsonova MD,
PhD c , Alexander Karaulov MD c , Min Xie MD d , Harald Renz MD a b c …

Background Although molecular tests are considered the reference standard for coronavirus
disease 2019 (COVID-19) diagnostics, serological and immunological tests may be useful …

In less than half a century, allergy, originally perceived as a rare disease, has become a
major public health threat, today affecting the lives of more than 60 million people in Europe, …

Neonatal necrotizing enterocolitis: an overview : Current Opinion in Infectious Diseases
Neonatal necrotizing enterocolitis: an overview : Current Opinion in Infectious Diseases Log in …

Immunization is highly effective in preventing infectious diseases and therefore an
indispensable public health measure. Allergic patients deserve access to the same publicly …